Investor relations presents Q4 key messages | Evonik

Investor relations presents Q4 key messages | Evonik


Good morning, this is Ina and Tim from the Evonik IR Team. It is Q4 reporting morning and we are here in our board room where in a couple of hours the earnings conference call with our CEO and CFO will be taking place. Ute will be sitting here and Christian right here next to her. Exclusively for you we will now give you the sneak preview of the key messages of today. 2019 we delivered on what we promised. EBITDA is stable on prior year’s level. Free cash flow is even slightly above the guide at 700 million. For 2020 we expect the low growth environment to continue. There for sure are some opportunities for our businesses and some of them are already starting to materialize. We’re optimistic for most of our specialty businesses and we’ll see the first earnings contribution from our PerOxyChem acquisition. And we’ll continue to execute our cost efficiency measures. However visibility remains low and has even become lower given the recent outbreak of the corona virus. Therefore considering both, opportunities and risks, we decided to guide for an adjusted EBITDA range from 2 to 2.3 billion Euros. On the free cash flow side we are already a bit more optimistic today. We guide for another slight improvement in 2020 irrespective the given EBITDA range Tim just explained. Looking into our segments . . . Well, Tim. Don’t you think we should leave some messages open for the call this afternoon? As always, Ina you are perfectly right. I’m sure there will be lots more to discuss after the conference call this afternoon. And we, the Evonik IR Team, are always happy to answer your questions and further details later on. Until then, I would say all the best from our side and goodbye.

Comments

(0 Comments)

Your email address will not be published. Required fields are marked *